Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Nov 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4669995012 | Mixed phenotype acute leukemia (disorder) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4669996013 | MPAL - mixed phenotype acute leukaemia | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
4669997016 | Mixed phenotype acute leukemia | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4669998014 | MPAL - mixed phenotype acute leukemia | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
4669999018 | Mixed phenotype acute leukaemia | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5399566015 | A group of rare acute leukemias of ambiguous lineage characterized by the presence of separate populations of blasts of more than one lineage (bilineal), a single population of blasts coexpressing antigens of more than one lineage (biphenotypic), or a combination thereof. The diagnosis relies on immunophenotyping, the T-cell component being characterized by strong expression of cytoplasmic CD3, usually in the absence of surface CD3, the B-cell component expressing CD19, almost always together with CD10, cCD79a, CD22, or PAX5, while the most specific hallmark of the myeloid component is the presence of myeloperoxidase in the blast cytoplasm. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
5399567012 | A group of rare acute leukaemias of ambiguous lineage characterised by the presence of separate populations of blasts of more than one lineage (bilineal), a single population of blasts coexpressing antigens of more than one lineage (biphenotypic), or a combination thereof. The diagnosis relies on immunophenotyping, the T-cell component being characterised by strong expression of cytoplasmic CD3, usually in the absence of surface CD3, the B-cell component expressing CD19, almost always together with CD10, cCD79a, CD22, or PAX5, while the most specific hallmark of the myeloid component is the presence of myeloperoxidase in the blast cytoplasm. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Mixed phenotype acute leukemia (disorder) | Is a | Acute leukemia | true | Inferred relationship | Some | ||
Mixed phenotype acute leukemia (disorder) | Finding site | Bone marrow structure | true | Inferred relationship | Some | 1 | |
Mixed phenotype acute leukemia (disorder) | Associated morphology | Mixed phenotype acute leukaemia | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Acute biphenotypic leukaemia | Is a | True | Mixed phenotype acute leukemia (disorder) | Inferred relationship | Some | |
Mixed phenotype acute leukemia with myeloid and B-cell lymphoid phenotypes | Is a | True | Mixed phenotype acute leukemia (disorder) | Inferred relationship | Some | |
Mixed phenotype acute leukemia with T-cell and myeloid lineage (disorder) | Is a | True | Mixed phenotype acute leukemia (disorder) | Inferred relationship | Some | |
Mixed phenotype acute leukemia with t(9;22) (q34;q11.2); BCR-ABL1 (disorder) | Is a | True | Mixed phenotype acute leukemia (disorder) | Inferred relationship | Some |
Reference Sets
Component annotation with string value reference set (foundation metadata concept)